Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-21 4:30 pm Purchase |
2022-11-18 | 13D | G1 Therapeutics, Inc. GTHX |
ESHELMAN FREDRIC N | 4,766,074 9.260% |
1,072,479 (+29.04%) |
Filing History |
| 2023-02-13 4:06 pm Purchase |
2022-11-10 | 13D | Eyenovia, Inc. EYEN |
ESHELMAN FREDRIC N | 21,357 4.700% |
214 (+1.01%) |
Filing History |
| 2022-04-05 4:15 pm Purchase |
2022-03-29 | 13D | Aravive, Inc. ARAV |
ESHELMAN FREDRIC N | 10,111,882 34.000% |
5,806,201 (+134.85%) |
Filing History |
| 2022-01-05 6:32 pm Purchase |
2022-01-03 | 13D | Aravive, Inc. ARAV |
ESHELMAN FREDRIC N | 4,305,681 19.990% |
472,828 (+12.34%) |
Filing History |
| 2021-02-18 7:00 pm Purchase |
2021-02-12 | 13D | Aravive, Inc. ARAV |
ESHELMAN FREDRIC N | 3,832,853 19.800% |
2,901,755 (+311.65%) |
Filing History |
| 2020-08-28 4:34 pm Unchanged |
2020-08-19 | 13D | Eyenovia, Inc. EYEN |
ESHELMAN FREDRIC N | 21,143 6.800% |
0 (Unchanged) |
Filing History |
| 2020-08-14 4:37 pm Purchase |
2020-08-13 | 13D | Eyenovia, Inc. EYEN |
ESHELMAN FREDRIC N | 21,143 8.200% |
214 (+1.02%) |
Filing History |